{
  "query": "follow longest blood mmhg",
  "studies": {
    "protocolSection": [
      {
        "identificationModule": {
          "nctId": "NCT00089973",
          "briefTitle": "Study Of Ispinesib In Subjects With Breast Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2004-06-30",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2006-08-25",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Neoplasms, Breast"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 50,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07167238",
          "briefTitle": "The Effect of Video Game-Based Exercise Training in Patients With Interstitial Lung Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2026-01-25",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2026-11-25",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Interstitial Lung Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 42,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "20 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02880371",
          "briefTitle": "A Study of ARRY-382 in Combination With Pembrolizumab for the Treatment of Patients With Advanced Solid Tumors"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-09-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-10-24",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Advanced Solid Tumors"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 82,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03940703",
          "briefTitle": "A Study of Tepotinib Plus Osimertinib in Osimertinib Relapsed MET Amplified NSCLC (INSIGHT 2)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-09-19",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-05-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Non-small Cell Lung Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 140,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00265317",
          "briefTitle": "A Study In Patients With Non-Small Cell Lung Cancer Testing If Erlotinib Plus SU011248 (Sunitinib) Is Better Than Erlotinib Alone"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2006-06"
          },
          "completionDateStruct": {
            "date": "2012-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Carcinoma, Non-Small-Cell Lung"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 162,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00725712",
          "briefTitle": "Study of GSK1363089 in Metastatic Gastric Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2007-03-31"
          },
          "completionDateStruct": {
            "date": "2009-11-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Neoplasms, Gastrointestinal Tract"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 74,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00585195",
          "briefTitle": "A Study Of Oral PF-02341066, A C-Met/Hepatocyte Growth Factor Tyrosine Kinase Inhibitor, In Patients With Advanced Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2006-04-19",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-01-19",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Non-Small Cell Lung Cancer ALK-positive", "Non-Small Cell Lung Cancer c-Met Dependent", "Non-Small Cell Lung Cancer ROS Marker Positive", "Systemic Anaplastic Large-Cell Lymphoma", "Advanced Malignancies Except Leukemia"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 596,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06962683",
          "briefTitle": "Post-surgery Muscle Preservation and Pain Reduction Through Blood Flow Restriction Training in Orthopedic Spinal Surgery"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-03-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-01-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Muscle Atrophy", "Postoperative Pain", "Spondylolisthesis", "Spondylodiskitis"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 50,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "100 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02584634",
          "briefTitle": "Study to Evaluate Safety, Efficacy, Pharmacokinetics And Pharmacodynamics Of Avelumab In Combination With Either Crizotinib Or PF-06463922 In Patients With NSCLC. (Javelin Lung 101)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-12-18",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-07-13",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Non-Small Cell Lung Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 43,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01889238",
          "briefTitle": "Safety and Efficacy Study of Enzalutamide in Patients With Advanced, Androgen Receptor-Positive, Triple Negative Breast Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-06-12",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-01-10",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Advanced, Androgen Receptor Positive Triple Negative Breast Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 118,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "FEMALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01105533",
          "briefTitle": "A Dose Finding Study Of A New Medication, PF-00337210 That Will Possibly Decrease Blood Supply To Tumors"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2006-05"
          },
          "completionDateStruct": {
            "date": "2011-09",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Neoplasm"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 46,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04014010",
          "briefTitle": "Machine Learning Modeling of Intraoperative Hemodynamic Predictors of Postoperative Outcomes"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-01-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2017-12-31",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Perioperative/Postoperative Complications", "Morbidity, Multiple", "Surgery", "Anesthesia", "Death"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 35000,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "45 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06493123",
          "briefTitle": "Cardiopulmonary Rehabilitation In Heart Valve Surgery"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-04-29",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-01-29",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Heart Valve Diseases"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 60,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "25 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02573350",
          "briefTitle": "A Trial to Evaluate Safety, Tolerability, and Efficacy of Orally Administered OPC-67683"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2009-03-26",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2011-10-27",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Tuberculosis, Multidrug-Resistant"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 213,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "64 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00969553",
          "briefTitle": "Dose Finding Study of BI 6727 (Volasertib) in Patients With Various Solid Cancers"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2009-08"
          },
          "completionDateStruct": {
            "date": "2011-09",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Neoplasms"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 59,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01774721",
          "briefTitle": "ARCHER1050: A Study of Dacomitinib vs. Gefitinib in 1st-Line Treatment Of Advanced NSCLC."
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-05-09",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-01-27",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Non-small Cell Lung Cancer With EGFR-Activating Mutations"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 452,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "99 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04526899",
          "briefTitle": "A Study to Investigate the Novel Agent BNT111 and Cemiplimab in Combination or as Single Agents in Patients With Advanced Melanoma That Has Not Responded to Other Forms of Treatment"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-05-19",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Melanoma Stage III", "Melanoma Stage IV", "Unresectable Melanoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 184,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05261490",
          "briefTitle": "Study of Maplirpacept (PF-07901801) in Combination With PLD in Patients With Platinum-Resistant Ovarian Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-08-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-02-15",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Ovarian Cancer", "Ovarian Neoplasms", "Ovarian Carcinoma", "Fallopian Tube Cancer", "Epithelial Ovarian Cancer", "Primary Peritoneal Carcinoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 10,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "FEMALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07027969",
          "briefTitle": "Metabolic Surgery for Atrial Fibrillation Elimination"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2026-02-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2030-03-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Atrial Fibrillation", "Obesity and Obesity-related Medical Conditions"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 100,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01906866",
          "briefTitle": "Efficacy and Safety of Circadin® in the Treatment of Sleep Disturbances in Children With Neurodevelopment Disabilities"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-10"
          },
          "completionDateStruct": {
            "date": "2018-03-27",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Sleep Disorders"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 125,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "2 Years",
          "maximumAge": "17 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03909971",
          "briefTitle": "A Study of Lorlatinib in ALK Inhibitor-Treated ALK-Positive NSCLC in China"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-04-28",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-10-21",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Carcinoma, Non-Small-Cell Lung"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 109,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03225105",
          "briefTitle": "M3541 in Combination With Radiotherapy in Solid Tumors"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-09-06",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-04-27",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Solid Tumors"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 15,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04029428",
          "briefTitle": "Peptide Receptor Radionuclide Therapy in the Treatment of Advanced, Non-resectable and/or Symptomatic Tumors With SSTR Overexpression"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2004-11-02",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-01-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Neuroendocrine Tumors"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 150,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "85 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02224573",
          "briefTitle": "An Open Label Extension Study of Cannabidiol (GWP42003-P) in Children and Adults With Dravet or Lennox-Gastaut Syndromes"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-06-11",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-09-24",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Epilepsy", "Dravet Syndrome", "Lennox-Gastaut Syndrome"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 681,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "2 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04635631",
          "briefTitle": "STUDY OF TALAZOPARIB MONOTHERAPY IN CHINESE PARTICIPANTS WITH ADVANCED SOLID TUMORS"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-11-30",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-12-14",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Neoplasms"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 15,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00441337",
          "briefTitle": "A Study of MDX-1106 in Patients With Selected Refractory or Relapsed Malignancies"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2006-08"
          },
          "completionDateStruct": {
            "date": "2009-11",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Carcinoma, Non-Small-Cell Lung", "Colorectal Cancer", "Malignant Melanoma", "Renal Cancer", "Prostate Cancer"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 39,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03043313",
          "briefTitle": "Tucatinib Plus Trastuzumab in Patients With HER2+ Colorectal Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-06-23",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-11-02",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Metastatic Colorectal Adenocarcinoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 117,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01058655",
          "briefTitle": "RAD001 and AV-951 in Patients With Refractory, Metastatic Colorectal Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2010-02"
          },
          "completionDateStruct": {
            "date": "2015-04",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Gastrointestinal Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 56,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04194125",
          "briefTitle": "Personalized CAPTEM Radiopeptide Therapy of Advanced, Non-resectable Neuroendocrine Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-02-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-01-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Neuroendocrine Tumors"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 25,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "85 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03304821",
          "briefTitle": "Granulocyte-Macrophage Stimulating Factor (GM-CSF) in Peripheral Arterial Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-12-19",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Peripheral Artery Disease (PAD)"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 176,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "21 Years",
          "maximumAge": "85 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05910632",
          "briefTitle": "Eccentrically Reinforced Resistance Training vs. Traditional Resistance Training in Sedentary Older Women"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-05-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-12-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Depression", "Physical Functional Performance", "Executive Function"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 36,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "FEMALE",
          "minimumAge": "60 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00387764",
          "briefTitle": "Extension Study to VEG105192 to Assess Pazopanib in Patients With Advanced/Metastatic Renal Cell Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2006-09"
          },
          "completionDateStruct": {
            "date": "2012-10",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Carcinoma, Renal Cell"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 80,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02082210",
          "briefTitle": "A Study of Emibetuzumab in Combination With Ramucirumab (LY3009806) in Participants With Advanced Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-03-07",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-01-24",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Advanced Cancer", "Gastric Adenocarcinoma", "Gastroesophageal Junction Adenocarcinoma", "Hepatocellular Cancer", "Renal Cell Carcinoma", "Non-Small Cell Lung Cancer"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 97,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05046366",
          "briefTitle": "Development of an Artificial Intelligence System for Intelligent Pathological Diagnosis and Therapeutic Effect Prediction Based on Multimodal Data Fusion of Common Tumors and Major Infectious Diseases in the Respiratory System Using Deep Learning Technology."
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-10-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Artificial Intelligence", "Deep Learning", "Pathology, Molecular", "Medical Informatics", "Database", "Lung Cancer", "Pulmonary Tuberculosis", "Covid19"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 1000,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "90 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05315674",
          "briefTitle": "Markers of COPD Exacerbations"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-07-25",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["COPD", "COPD Exacerbation"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 150,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "40 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06721442",
          "briefTitle": "Effect of Dapagliflozin on Electrocardiographic Parameters in Type 2 Diabetes Patients: DAPA - ECG Study"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-01-10",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-07-10",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Arrhythmias, Cardiac", "Diabetes Mellitus"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 174,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01227928",
          "briefTitle": "Efficacy and Safety of Pazopanib Monotherapy After First-line Chemotherapy in Ovarian, Fallopian Tube, or Primary Peritoneal Cancer in Asian Women"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2010-09"
          },
          "completionDateStruct": {
            "date": "2014-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Neoplasms, Ovarian"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 145,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "FEMALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02576574",
          "briefTitle": "Avelumab in First-line NSCLC (JAVELIN Lung 100)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-10-29",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-01-29",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "First Line Non-Small Cell Lung Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 1214,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05596643",
          "briefTitle": "Investigation of Autonomic Dysfunction in Patients With Familial Mediterranean Fever"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-03-15",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-10-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Familial Mediterranean Fever", "Autonomic Dysfunction"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 60,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05138601",
          "briefTitle": "Remote Monitoring and Virtual Collaborative Care For Hypertension Control to Prevent Cognitive Decline Phase II"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-11-16",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Hypertension"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 1000,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07012967",
          "briefTitle": "Kinesio Taping in Obesity: Breathing and Sleep Implications"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-05-10",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-09-05",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Obesity"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 36,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06980311",
          "briefTitle": "Comparing Music-Supported and Traditional Aerobic Training in Geriatric Health Outcomes"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-06-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2027-06-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Geriatric", "Aerobic Exercise", "Music Therapy", "Physiotherapy and Rehabilitation"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 33,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04652102",
          "briefTitle": "A Phase 2b/3, Randomized, Observer-Blinded, Placebo-Controlled, Multicenter Clinical Study Evaluating the Efficacy and Safety of Investigational SARS-CoV-2 mRNA Vaccine CVnCoV in Adults 18 Years of Age and Older"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-12-11",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-06-10",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Covid19", "SARS-CoV-2"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 39680,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03052608",
          "briefTitle": "A Study Of Lorlatinib Versus Crizotinib In First Line Treatment Of Patients With ALK-Positive NSCLC"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-04-27",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Carcinoma, Non-Small-Cell Lung"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 296,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07007884",
          "briefTitle": "Effect of Transauricular Vagal Stimulation on Cardiac Function After Spinal Cord Injury"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-03-20",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-09-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Spinal Cord Injury (SCI)"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 30,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "60 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02315755",
          "briefTitle": "Observational Study Evaluating The Efficacy And Effects On Quality Of Life Of Targeted Treatments Following TKIs In mRCC"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-05-11",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2017-11-20",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Renal Cell Carcinoma"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 102,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01347866",
          "briefTitle": "Clinical Study Of PI3K/mTOR Inhibitors In Combination With An Oral MEK Inhibitor Or Irinotecan In Patients With Advanced Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2011-10",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2015-12",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Advanced Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 105,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00421200",
          "briefTitle": "Phase III Study of Hemospan® to Prevent Hypotension in Hip Arthroplasty"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2007-02"
          },
          "completionDateStruct": {
            "date": "2008-06",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Hypotension", "Ischemia"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 375,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01922154",
          "briefTitle": "Intravitreous Ranibizumab as Adjunctive Treatment for Trabeculectomy in Neovascular Glaucoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2009-02"
          },
          "completionDateStruct": {
            "date": "2012-12",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Glaucoma, Neovascular"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 15,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06926673",
          "briefTitle": "Platform Trial of Novel Regimens Versus Standard of Care (SoC) in Participants With Non-small Cell Lung Cancer (NSCLC) - Sub-study 3"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-12-23",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-05-02",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Neoplasms"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 62,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06515795",
          "briefTitle": "Evaluation of Two Isometric Exercises in the Reduction of the Blood Pressure in People With Resistant Hypertension"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-07-11",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-09",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Resistant Hypertension"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 15,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "40 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04676763",
          "briefTitle": "Substance P Challenge in Healthy Participants"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-03-02",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-07-21",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Skin Diseases"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 32,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02215096",
          "briefTitle": "Dose-finding Study of GSK2636771 When Administered in Combination With Enzalutamide in Male Subjects With Metastatic Castration-Resistant Prostate Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-11-13",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-10-03",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Neoplasms"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 37,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "MALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07237425",
          "briefTitle": "Intralesional Ronkyla Plus Injection for the Treatment of Superficial Lipoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-11-14",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-01-14",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Lipoma", "Submental Fullness"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 56,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04101877",
          "briefTitle": "The Sahlgrenska Anti-VEGF Study"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-09-03",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-05",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Neovascular Age-related Macular Degeneration"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 402,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "50 Years"
        }
      }
    ]
  }
}
